Fig. 1.
Fig. 1. A rescued immunoglobulin from an HCV-associated lymphoma binds soluble E2661. / (A) An anti-E2 mAb, CBH-4G (▾),27 HCV-associated immunoglobulin (patient 1, ⋄), HCV-associated immunoglobulin (patient 2, ○) and non-HCV lymphoma immunoglobulin controls (n = 23; ▪) were serially diluted and added to E2661-coated wells, and bound immunoglobulin was determined by ELISA. (B) Supernatants from AdV-infected HeLa cells expressing HCV-E2661 (lanes 1, 3, and 5) or LacZ (lanes 2, 4, and 6) were immunoprecipitated with immunoglobulins derived from an anti-E2 mAb (CBH-4G) and from the 2 HCV-associated lymphoma cases. Proteins were separated by SDS-PAGE, and blots were probed with an antibody against HCV-E2. Sizes (in kd) of protein markers are indicated on the right, and the bracket on the left indicates the precipitated heterogeneously glycosylated E2661 protein.

A rescued immunoglobulin from an HCV-associated lymphoma binds soluble E2661.

(A) An anti-E2 mAb, CBH-4G (▾),27 HCV-associated immunoglobulin (patient 1, ⋄), HCV-associated immunoglobulin (patient 2, ○) and non-HCV lymphoma immunoglobulin controls (n = 23; ▪) were serially diluted and added to E2661-coated wells, and bound immunoglobulin was determined by ELISA. (B) Supernatants from AdV-infected HeLa cells expressing HCV-E2661 (lanes 1, 3, and 5) or LacZ (lanes 2, 4, and 6) were immunoprecipitated with immunoglobulins derived from an anti-E2 mAb (CBH-4G) and from the 2 HCV-associated lymphoma cases. Proteins were separated by SDS-PAGE, and blots were probed with an antibody against HCV-E2. Sizes (in kd) of protein markers are indicated on the right, and the bracket on the left indicates the precipitated heterogeneously glycosylated E2661 protein.

Close Modal

or Create an Account

Close Modal
Close Modal